{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:17:26Z","timestamp":1778887046637,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD22\/00026"],"award-info":[{"award-number":["CD22\/00026"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII22\/00004"],"award-info":[{"award-number":["CPII22\/00004"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IDISBA - Impetus Call","award":["IMP21\/10"],"award-info":[{"award-number":["IMP21\/10"]}]},{"DOI":"10.13039\/501100022397","name":"Govern de les Illes Balears","doi-asserted-by":"publisher","award":["Margalida Comas"],"award-info":[{"award-number":["Margalida Comas"]}],"id":[{"id":"10.13039\/501100022397","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IDISBA - Llavor"},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IDISBA - FOLIUM"},{"DOI":"10.13039\/501100015079","name":"Fundaci\u00f3n Francisco Cobos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015079","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EASI-Genomics"},{"name":"Fundaci\u00f3n Contigo Contra el Cancer de Mujer"},{"name":"IDISBA - Garc\u00eda Palmer"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triple-negative breast cancer (TNBC) is an aggressive subtype that exhibits a high incidence of distant metastases and lacks targeted therapeutic options. Here we explored how the epigenome contributes to matrix metalloprotease (MMP) dysregulation impacting tumor invasion, which is the first step of the metastatic process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We combined RNA expression and chromatin interaction data to identify insulator elements potentially associated with MMP gene expression and invasion. We employed CRISPR\/Cas9 to disrupt the CCCTC-Binding Factor (CTCF) binding site on an insulator element downstream of the MMP8 gene (IE8) in two TNBC cellular models. We characterized these models by combining Hi-C, ATAC-seq, and RNA-seq with functional experiments to determine invasive ability. The potential of our findings to predict the progression of ductal carcinoma in situ (DCIS), was tested in data from clinical specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We explored the clinical relevance of an insulator element located within the Chr11q22.2 locus, downstream of the MMP8 gene (IE8). This regulatory element resulted in a topologically associating domain (TAD) boundary that isolated nine MMP genes into two anti-correlated expression clusters. This expression pattern was associated with worse relapse-free (HR\u2009=\u20091.57 [1.06\u2009\u2212\u20092.33]; p\u2009=\u20090.023) and overall (HR\u2009=\u20092.65 [1.31\u2009\u2212\u20095.37], p\u2009=\u20090.005) survival of TNBC patients. After CRISPR\/Cas9-mediated disruption of IE8, cancer cells showed a switch in the MMP expression signature, specifically downregulating the pro-invasive MMP1 gene and upregulating the antitumorigenic MMP8 gene, resulting in reduced invasive ability and collagen degradation. We observed that the MMP expression pattern predicts DCIS that eventually progresses into invasive ductal carcinomas (AUC\u2009=\u20090.77, p\u2009&lt;\u20090.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrates how the activation of an IE near the MMP8 gene determines the regional transcriptional regulation of MMP genes with opposing functional activity, ultimately influencing the invasive properties of aggressive forms of breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12943-023-01906-8","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T05:02:17Z","timestamp":1701147737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors"],"prefix":"10.1186","volume":"22","author":[{"given":"Pere","family":"Llin\u00e0s-Arias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Ensenyat-Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"\u00cd\u00f1iguez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier I. J.","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Matsuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Solivellas-Pieras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s F.","family":"Bedoya-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Ses\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Mezger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Ormestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Unzueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri H.","family":"Strand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander D.","family":"Boiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie L.","family":"DiNome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Lupien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego M.","family":"Marzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"1906_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1906_CR2","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MCU, Voduc D, Speers CH, et al. Metastatic behavior of Breast cancer subtypes. J Clin Oncol. 2010;28:3271\u20137.","journal-title":"J Clin Oncol"},{"key":"1906_CR3","doi-asserted-by":"crossref","unstructured":"Ensenyat-Mendez M, Llin\u00e0s-Arias P, Orozco JIJ, \u00cd\u00f1iguez-Mu\u00f1oz S, Salomon MP, Ses\u00e9 B et al. Current triple-negative Breast Cancer subtypes: dissecting the most aggressive form of Breast Cancer. Front Oncol. 2021;2311.","DOI":"10.3389\/fonc.2021.681476"},{"key":"1906_CR4","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillek\u00e5s","year":"2019","unstructured":"Dillek\u00e5s H, Rogers MS, Straume O. Are 90% of deaths from Cancer caused by metastases? Cancer Med. 2019;8:5574\u20136.","journal-title":"Cancer Med"},{"key":"1906_CR5","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.celrep.2016.06.051","volume":"16","author":"R Lesurf","year":"2016","unstructured":"Lesurf R, Aure MR, M\u00f8rk HH, Vitelli V, Oslo Breast Cancer Research Consortium (OSBREAC), Lundgren S, et al. Molecular features of subtype-specific progression from Ductal Carcinoma in situ to invasive Breast Cancer. Cell Rep. 2016;16:1166\u201379.","journal-title":"Cell Rep"},{"key":"1906_CR6","doi-asserted-by":"crossref","unstructured":"van Seijen M, Lips EH, Thompson AM, Nik-Zainal S, Futreal A, Hwang ES et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019;121:285\u201392.","DOI":"10.1038\/s41416-019-0478-6"},{"key":"1906_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA. Biochemical and biological attributes of Matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1\u201373.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1906_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox TR. The matrix in cancer. Nat Rev Cancer. 2021;21:217\u201338.","journal-title":"Nat Rev Cancer"},{"key":"1906_CR9","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Rosa CC-D, la, Ramirez-Acuna JM, Perez-Romero BA, Guerrero-Rodriguez JF, et al. The roles of matrix metalloproteinases and their inhibitors in human Diseases. Int J Mol Sci. 2020;21:9739.","journal-title":"Int J Mol Sci"},{"key":"1906_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5768-0","volume":"19","author":"E Gobin","year":"2019","unstructured":"Gobin E, Bagwell K, Wagner J, Mysona D, Sandirasegarane S, Smith N, et al. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic\/prognostic potential. BMC Cancer. 2019;19:1\u201310.","journal-title":"BMC Cancer"},{"key":"1906_CR11","doi-asserted-by":"crossref","unstructured":"Owyong M, Chou J, Bijgaart RJE, van den, Kong N, Efe G, Maynard C et al. MMP9 modulates the metastatic cascade and immune landscape for Breast cancer anti-metastatic therapy. Life Sci Alliance. 2019;2.","DOI":"10.26508\/lsa.201800226"},{"key":"1906_CR12","first-page":"1732","volume":"17","author":"Q-M Wang","year":"2019","unstructured":"Wang Q-M, Lv L, Tang Y, Zhang L, Wang L-F. MMP\u20131 is overexpressed in triple\u2013negative Breast cancer tissues and the knockdown of MMP\u20131 expression inhibits Tumor cell malignant behaviors in vitro. Oncol Lett. 2019;17:1732\u201340.","journal-title":"Oncol Lett"},{"key":"1906_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-07860-2","volume":"21","author":"H Jiang","year":"2021","unstructured":"Jiang H, Li H. Prognostic values of tumoral MMP2 and MMP9 overexpression in Breast cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21:1\u201313.","journal-title":"BMC Cancer"},{"key":"1906_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-8-77","volume":"8","author":"J Decock","year":"2008","unstructured":"Decock J, Hendrickx W, Vanleeuw U, Belle VV, Huffel SV, Christiaens M-R, et al. Plasma MMP1 and MMP8 expression in Breast cancer: protective role of MMP8 against lymph node Metastasis. BMC Cancer. 2008;8:1\u20138.","journal-title":"BMC Cancer"},{"key":"1906_CR15","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.3390\/ijms20184506","volume":"20","author":"K Juurikka","year":"2019","unstructured":"Juurikka K, Butler GS, Salo T, Nyberg P, \u00c5str\u00f6m P. The role of MMP8 in cancer: a systematic review. Int J Mol Sci. 2019;20:4506.","journal-title":"Int J Mol Sci"},{"key":"1906_CR16","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-07-5154","volume":"68","author":"A Guti\u00e9rrez-Fern\u00e1ndez","year":"2008","unstructured":"Guti\u00e9rrez-Fern\u00e1ndez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, et al. Matrix metalloproteinase-8 functions as a Metastasis suppressor through modulation of Tumor cell adhesion and invasion. Cancer Res. 2008;68:2755\u201363.","journal-title":"Cancer Res"},{"key":"1906_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fphar.2012.00140","volume":"3","author":"A No\u00ebl","year":"2012","unstructured":"No\u00ebl A, Guti\u00e9rrez-Fern\u00e1ndez A, Sounni NE, Behrendt N, Maquoi E, Lund IK, et al. New and paradoxical roles of matrix metalloproteinases in the Tumor microenvironment. Front Pharmacol. 2012;3:140.","journal-title":"Front Pharmacol"},{"key":"1906_CR18","doi-asserted-by":"crossref","unstructured":"Chernov AV, Strongin AY. Epigenetic regulation of matrix metalloproteinases and their collagen substrates in cancer. Biomol Concepts. 2011;2(3):135\u201347.","DOI":"10.1515\/bmc.2011.017"},{"key":"1906_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/jnci\/95.4.327","volume":"95","author":"N Sato","year":"2003","unstructured":"Sato N, Maehara N, Su GH, Goggins M. Effects of 5-aza-2\u2032-deoxycytidine on matrix metalloproteinase expression and Pancreatic cancer cell invasiveness. J Natl Cancer Inst. 2003;95:327\u201330.","journal-title":"J Natl Cancer Inst"},{"key":"1906_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.gene.2017.11.054","volume":"642","author":"LMB Klassen","year":"2018","unstructured":"Klassen LMB, Chequin A, Manica GCM, Biembengut IV, Toledo MB, Baura VA, et al. MMP9 gene expression regulation by intragenic epigenetic modifications in Breast cancer. Gene. 2018;642:461\u20136.","journal-title":"Gene"},{"key":"1906_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/cells11010075","volume":"11","author":"SI Nu\u00f1ez-Olvera","year":"2021","unstructured":"Nu\u00f1ez-Olvera SI, Puente-Rivera J, Ramos-Pay\u00e1n R, P\u00e9rez-Plasencia C, Salinas-Vera YM, Aguilar-Arnal L, et al. Three-Dimensional Genome Organization in breast and gynecological cancers: how chromatin folding influences Tumorigenic Transcriptional Programs. Cells. 2021;11:75.","journal-title":"Cells"},{"key":"1906_CR22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/JCO.19.02309","volume":"38","author":"KH Allison","year":"2020","unstructured":"Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, et al. Estrogen and progesterone receptor testing in Breast Cancer: ASCO\/CAP Guideline Update. J Clin Oncol off J Am Soc Clin Oncol. 2020;38:1346\u201366.","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"1906_CR23","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, et al. Human epidermal growth factor receptor 2 testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol off J Am Soc Clin Oncol. 2018;36:2105\u201322.","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"1906_CR24","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1038\/ncomms9971","volume":"6","author":"D Aran","year":"2015","unstructured":"Aran D, Sirota M, Butte AJ. Systematic pan-cancer analysis of tumour purity. Nat Commun. 2015;6:8971.","journal-title":"Nat Commun"},{"key":"1906_CR25","doi-asserted-by":"publisher","first-page":"W774","DOI":"10.1093\/nar\/gkac238","volume":"50","author":"D Li","year":"2022","unstructured":"Li D, Purushotham D, Harrison JK, Hsu S, Zhuo X, Fan C, et al. WashU Epigenome Browser update 2022. Nucleic Acids Res. 2022;50:W774\u2013781.","journal-title":"Nucleic Acids Res"},{"key":"1906_CR26","doi-asserted-by":"publisher","first-page":"e27633","DOI":"10.2196\/27633","volume":"23","author":"A L\u00e1nczky","year":"2021","unstructured":"L\u00e1nczky A, Gy\u0151rffy B. Web-based Survival Analysis Tool tailored for Medical Research (KMplot): development and implementation. J Med Internet Res. 2021;23:e27633.","journal-title":"J Med Internet Res"},{"key":"1906_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GTEx Consortium","year":"2013","unstructured":"GTEx Consortium. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580\u20135.","journal-title":"Nat Genet"},{"key":"1906_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569:503\u20138.","journal-title":"Nature"},{"key":"1906_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","unstructured":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature. 2020;578:82\u201393.","journal-title":"Nature"},{"key":"1906_CR30","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41591-019-0582-4","volume":"25","author":"J Staaf","year":"2019","unstructured":"Staaf J, Glodzik D, Bosch A, Vallon-Christersson J, Reutersw\u00e4rd C, H\u00e4kkinen J, et al. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. Nat Med. 2019;25:1526\u201333.","journal-title":"Nat Med"},{"key":"1906_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-015-0131-9","volume":"7","author":"LH Saal","year":"2015","unstructured":"Saal LH, Vallon-Christersson J, H\u00e4kkinen J, Hegardt C, Grabau D, Winter C, et al. The Sweden Cancerome Analysis network-breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of Breast cancer genomic analyses in the clinical routine. Genome Med. 2015;7:1\u201312.","journal-title":"Genome Med"},{"key":"1906_CR32","doi-asserted-by":"crossref","unstructured":"Staaf J, H\u00e4kkinen J, Hegardt C, Saal LH, Kimbung S, Hedenfalk I et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. Npj Breast Cancer. 2022;8:1\u201317.","DOI":"10.1038\/s41523-022-00465-3"},{"key":"1906_CR33","doi-asserted-by":"crossref","unstructured":"Strand SH, Rivero-Guti\u00e9rrez B, Houlahan KE, Seoane JA, King LM, Risom T et al. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell. 2022;40:1521\u20131536.e7.","DOI":"10.1016\/j.ccell.2022.10.021"},{"key":"1906_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:1\u201314.","journal-title":"Genome Biol"},{"key":"1906_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ceb.2019.02.001","volume":"58","author":"D Chen","year":"2019","unstructured":"Chen D, Lei EP. Function and regulation of chromatin insulators in dynamic genome organization. Curr Opin Cell Biol. 2019;58:61\u20138.","journal-title":"Curr Opin Cell Biol"},{"key":"1906_CR36","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.xpro.2022.101529","volume":"3","author":"A Panday","year":"2022","unstructured":"Panday A, Elango R, Willis NA, Scully R. A modified CUT&RUN-seq technique for qPCR analysis of chromatin-protein interactions. STAR Protoc. 2022;3:101529.","journal-title":"STAR Protoc"},{"key":"1906_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.molcel.2015.09.023","volume":"60","author":"E de Wit","year":"2015","unstructured":"de Wit E, Vos ESM, Holwerda SJB, Valdes-Quezada C, Verstegen MJAM, Teunissen H, et al. CTCF binding polarity determines chromatin looping. Mol Cell. 2015;60:676\u201384.","journal-title":"Mol Cell"},{"key":"1906_CR38","doi-asserted-by":"crossref","unstructured":"Gong Y, Ji P, Yang Y-S, Xie S, Yu T-J, Xiao Y et al. Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets. Cell Metab. 2021;33:51\u201364.e9.","DOI":"10.1016\/j.cmet.2020.10.012"},{"key":"1906_CR39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1023\/A:1006639214618","volume":"17","author":"U Benbow","year":"1999","unstructured":"Benbow U, Schoenermark MP, Orndorff KA, Givan AL, Brinckerhoff CE. Human Breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid. Clin Exp Metastasis. 1999;17:231\u20138.","journal-title":"Clin Exp Metastasis"},{"key":"1906_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12032-020-01447-w","volume":"38","author":"J Majidpoor","year":"2021","unstructured":"Majidpoor J, Mortezaee K. Steps in Metastasis: an updated review. Med Oncol Northwood Lond Engl. 2021;38:3.","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"1906_CR41","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.4161\/cbt.21187","volume":"13","author":"MP Roberti","year":"2012","unstructured":"Roberti MP, Arriaga JM, Bianchini M, Quint\u00e1 HR, Bravo AI, Levy EM, et al. Protein expression changes during human triple negative Breast cancer cell line progression to lymph node Metastasis in a xenografted model in nude mice. Cancer Biol Ther. 2012;13:1123\u201340.","journal-title":"Cancer Biol Ther"},{"key":"1906_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10549-022-06514-6","volume":"193","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Tao Z, Chen Y, Lin S, Zhu M, Ji W, et al. Exosomal MMP-1 transfers Metastasis potential in triple-negative Breast cancer through PAR1-mediated EMT. Breast Cancer Res Treat. 2022;193:65\u201381.","journal-title":"Breast Cancer Res Treat"},{"key":"1906_CR43","doi-asserted-by":"crossref","unstructured":"Si W, Xu X, Wan L, Lv F, Wei W, Xu X et al. RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1. Front Oncol. 2022;12.","DOI":"10.3389\/fonc.2022.996080"},{"key":"1906_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canlet.2019.03.014","volume":"452","author":"JP Lim","year":"2019","unstructured":"Lim JP, Nair S, Shyamasundar S, Chua PJ, Muniasamy U, Matsumoto K, et al. Silencing Y-box binding protein-1 inhibits triple-negative Breast cancer cell invasiveness via regulation of MMP1 and beta-catenin expression. Cancer Lett. 2019;452:119\u201331.","journal-title":"Cancer Lett"},{"key":"1906_CR45","doi-asserted-by":"publisher","first-page":"16282","DOI":"10.1074\/jbc.M113.464230","volume":"288","author":"S Thirkettle","year":"2013","unstructured":"Thirkettle S, Decock J, Arnold H, Pennington CJ, Jaworski DM, Edwards DR. Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in Breast cancer cells. J Biol Chem. 2013;288:16282\u201394.","journal-title":"J Biol Chem"},{"key":"1906_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13058-015-0545-8","volume":"17","author":"J Decock","year":"2015","unstructured":"Decock J, Hendrickx W, Thirkettle S, Guti\u00e9rrez-Fern\u00e1ndez A, Robinson SD, Edwards DR. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice. Breast Cancer Res BCR. 2015;17:38.","journal-title":"Breast Cancer Res BCR"},{"key":"1906_CR47","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/onc.2013.267","volume":"33","author":"C Soria-Valles","year":"2014","unstructured":"Soria-Valles C, Guti\u00e9rrez-Fern\u00e1ndez A, Guiu M, Mari B, Fueyo A, Gomis RR, et al. The anti-metastatic activity of collagenase-2 in Breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. Oncogene. 2014;33:3054\u201363.","journal-title":"Oncogene"},{"key":"1906_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13058-017-0822-9","volume":"19","author":"M Sarper","year":"2017","unstructured":"Sarper M, Allen MD, Gomm J, Haywood L, Decock J, Thirkettle S, et al. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function. Breast Cancer Res BCR. 2017;19:33.","journal-title":"Breast Cancer Res BCR"},{"key":"1906_CR49","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00432-010-0782-2","volume":"136","author":"LO Gonz\u00e1lez","year":"2010","unstructured":"Gonz\u00e1lez LO, Gonz\u00e1lez-Reyes S, Junquera S, Mar\u00edn L, Gonz\u00e1lez L, Del Casar JM, et al. Expression of metalloproteases and their inhibitors by Tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events. J Cancer Res Clin Oncol. 2010;136:1313\u201321.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1906_CR50","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","volume":"159","author":"SSP Rao","year":"2014","unstructured":"Rao SSP, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014;159:1665\u201380.","journal-title":"Cell"},{"key":"1906_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature16490","volume":"529","author":"WA Flavahan","year":"2016","unstructured":"Flavahan WA, Drier Y, Liau BB, Gillespie SM, Venteicher AS, Stemmer-Rachamimov AO, et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature. 2016;529:110\u20134.","journal-title":"Nature"},{"key":"1906_CR52","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cell.2015.07.038","volume":"162","author":"Y Guo","year":"2015","unstructured":"Guo Y, Xu Q, Canzio D, Shou J, Li J, Gorkin DU, et al. CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer\/Promoter function. Cell. 2015;162:900\u201310.","journal-title":"Cell"},{"key":"1906_CR53","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cels.2019.04.001","volume":"8","author":"EM Liu","year":"2019","unstructured":"Liu EM, Martinez-Fundichely A, Diaz BJ, Aronson B, Cuykendall T, MacKay M, et al. Identification of Cancer drivers at CTCF insulators in 1,962 whole genomes. Cell Syst. 2019;8:446\u2013455e8.","journal-title":"Cell Syst"},{"key":"1906_CR54","doi-asserted-by":"crossref","unstructured":"Liu F, Wu D, Wang X. Roles of CTCF in conformation and functions of chromosome. Semin Cell Dev Biol. 2019;90.","DOI":"10.1016\/j.semcdb.2018.07.021"},{"key":"1906_CR55","doi-asserted-by":"crossref","unstructured":"Llin\u00e0s-Arias P, Ensenyat-M\u00e9ndez M, Orozco JIJ, \u00cd\u00f1iguez-Mu\u00f1oz S, Valdez B, Wang C et al. 3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer. BMC Genomic Data. 2023;24:61.","DOI":"10.1186\/s12863-023-01166-x"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01906-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-023-01906-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01906-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T06:09:59Z","timestamp":1701151799000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-023-01906-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1906"],"URL":"https:\/\/doi.org\/10.1186\/s12943-023-01906-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2909119\/v1","asserted-by":"object"}]},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"8 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Research Board of Hospital Universitario Son Espases (Code CI-542-21). It was performed following the Declaration of Helsinki. Written informed consent was obtained from each patient included by the original institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors revised and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}